Clinolipid (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Clinolipid drug offered from Baxter Healthcare Corporation. This Lipid Emulsion [EPC],Lipids [Chemical/Ingredient],Lipid Emulsion [EPC],Lipids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: Olive Oil and Soybean Oil
SUBSTANCE NAME: OLIVE OIL; SOYBEAN OIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lipid Emulsion [EPC],Lipids [Chemical/Ingredient],Lipid Emulsion [EPC],Lipids [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, EMULSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-01-01
END MARKETING DATE: 0000-00-00


Clinolipid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionClinolipid from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 16; 4(g/100mL; g/100mL)
START MARKETING DATE: 2016-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-9540_0e80cf66-7b95-4535-bb8e-8a79b90b705c
PRODUCT NDC: 0338-9540
APPLICATION NUMBER: NDA204508

Other OLIVE OIL; SOYBEAN OIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationClinolipid